Madison El-Saadi
Stock Analyst at B. Riley Securities
(4.59)
# 458
Out of 5,182 analysts
16
Total ratings
73.33%
Success rate
24.51%
Average return
Main Sectors:
Stocks Rated by Madison El-Saadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMPS COMPASS Pathways | Initiates: Buy | $17 | $8.89 | +91.23% | 1 | Apr 24, 2026 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $26 → $31 | $23.45 | +32.20% | 4 | Mar 20, 2026 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $50 → $63 | $35.10 | +79.49% | 3 | Mar 13, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $61 → $101 | $73.60 | +37.23% | 1 | Jan 22, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintains: Buy | $11 → $14 | $6.79 | +106.19% | 2 | Dec 31, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $37 | $6.94 | +433.14% | 4 | Dec 12, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $179 | $187.40 | -4.48% | 1 | Oct 1, 2025 |
COMPASS Pathways
Apr 24, 2026
Initiates: Buy
Price Target: $17
Current: $8.89
Upside: +91.23%
Eton Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $26 → $31
Current: $23.45
Upside: +32.20%
Capricor Therapeutics
Mar 13, 2026
Maintains: Buy
Price Target: $50 → $63
Current: $35.10
Upside: +79.49%
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintains: Buy
Price Target: $61 → $101
Current: $73.60
Upside: +37.23%
Vanda Pharmaceuticals
Dec 31, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $6.79
Upside: +106.19%
Wave Life Sciences
Dec 12, 2025
Maintains: Buy
Price Target: $19 → $37
Current: $6.94
Upside: +433.14%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $187.40
Upside: -4.48%